Clinical review
We assess psychiatric diagnosis, prior treatment response, medical history, medications, substance-use risk, cardiovascular considerations, and alternatives.
KETAMINE TREATMENT
A carefully selected
off-label psychiatric option.
Ketamine is FDA-approved as an anesthetic; psychiatric use is off-label. CA Cortex considers ketamine treatment only after individualized psychiatric and medical evaluation.
PHYSICIAN-GUIDED CARE
Selection and safety matter.
Informed consent
Because psychiatric ketamine treatment is off-label, expected benefits, uncertainties, alternatives, adverse effects, and monitoring are discussed before treatment.
Monitoring & reassessment
Protocol, route, schedule, and monitoring depend on the individual program and clinical assessment, with response reassessed over time.